# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-106374
Filing Date
2021-08-16
Accepted
2021-08-16 16:30:34
Documents
4
Period of Report
2021-09-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2123771d2_def14a.htm | DEF 14A | 400939
2 | GRAPHIC | tm2123771d2_def14aimg001.jpg | GRAPHIC | 5408
3 | GRAPHIC | tm2123771d2_def14aimg002.jpg | GRAPHIC | 333694
4 | GRAPHIC | tm2123771d2_def14aimg003.jpg | GRAPHIC | 288562
| Complete submission text file | 0001104659-21-106374.txt |  | 1267127

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12584 | Film No.: 211178841
SIC: 2834 Pharmaceutical Preparations